You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leishmaniasis, Mucocutaneous

Showing 1 - 25 of 231
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal

Recruiting
  • Leishmaniasis; Brazilian
  • Leishmaniasis, Mucocutaneous
  • Miltefosine 50mg
  • +2 more
  • Brasilia, DF, Brazil
    Hospital Universitario de Brasilia
Sep 13, 2023

Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal

Recruiting
  • Mucosal Leishmaniasis
  • Group 1: Miltefosine
  • +2 more
  • Santa Cruz de la Sierra, SC, Bolivia
    Hospital Dermatologico de Jorochito
Jun 14, 2022

Mucosal Leishmaniasis, Cutaneous Leishmaniasis Trial run by the USA (Miltefosine)

Completed
Has Results
  • Mucosal Leishmaniasis
  • Cutaneous Leishmaniasis
  • Bethesda, Maryland
  • +1 more
Sep 8, 2020

Bolivian Patients Taking Impavido® for Mucocutaneous

Completed
  • Mucocutaneous Leishmaniasis
  • Santa Cruz, Bolivia
    Funderma
Sep 2, 2020

Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous Trial in San Francisco (sodium stibogluconate (Pentostam))

Available
  • Leishmaniasis, Cutaneous
  • Leishmaniasis, Mucocutaneous
  • sodium stibogluconate (Pentostam)
  • San Francisco, California
    University of CA at San Francisco Hospitals and Clinics
Mar 6, 2020

Cutaneous Leishmaniases Trial in Gondar (skin biopsy, venous blood sample (plasma, PBMC, WB), venous blood sample (HLA))

Recruiting
  • Cutaneous Leishmaniases
  • skin biopsy
  • +3 more
  • Gondar, Amhara, Ethiopia
    University of Gondar
Apr 11, 2022

Bolivian Patients Taking Impavido® for Mucocutaneous

Completed
  • Mucocutaneous Leishmaniasis
  • Santa Cruz, Bolivia
    Funderama
Feb 28, 2019

Cases of Cutaneous Leishmaniasis Treated With Miltefosine in

Not yet recruiting
  • Cutaneous Leishmaniases
  • +3 more
  • Data collection
  • Questionnaires
  • (no location specified)
Aug 5, 2022

Leishmaniasis, Cutaneous Trial in Medellín (Arnica Tincture)

Not yet recruiting
  • Leishmaniasis, Cutaneous
  • Arnica Tincture
  • Medellín, Antioquia, Colombia
    Program for Research and Control in Tropical Diseases - PECET
Jun 4, 2022

SSG/Allopurinol Combination Treatment in Ethiopia

Recruiting
  • Cutaneous Leishmaniasis
  • Sodium Stibogluconate with allopurinol
  • Dessie, Ethiopia
    Boru Meda Hospital
Mar 7, 2022

Leishmaniasis, Cutaneous Trial in Medellín (Experimental topical (Curaleish Topical))

Withdrawn
  • Leishmaniasis, Cutaneous
  • Experimental topical (Curaleish Topical)
  • Medellín, Antioquia, Colombia
    Program for Research and Control in Tropical Diseases - PECET
Jun 2, 2022

Leishmaniasis Trial in Washington (Sodium Stibogluconate (SSG))

Completed
Has Results
  • Leishmaniasis
  • Sodium Stibogluconate (SSG)
  • Washington, District of Columbia
    Walter Reed Army Medical Center
Feb 10, 2021

Withdrawal of Colchicine in Behçet Syndrome

Not yet recruiting
  • Behçet's Syndrome
  • (no location specified)
Nov 17, 2023

Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis Trial in Rio de Janeiro (Meglumine antimoniate)

Unknown status
  • Mucosal Leishmaniasis
  • Mucocutaneous Leishmaniasis
  • Meglumine antimoniate
  • Rio de Janeiro, Brazil
    Oswaldo Cruz Foundation - IPEC/FIOCRUZ
Jul 10, 2018

HSV Infection Trial (walnut extract)

Completed
  • HSV Infection
  • walnut extract
  • (no location specified)
Oct 16, 2023

Chronic Kidney Diseases, Manifestation, Skin Trial (observe pattern of mucocutaneous manifestations in chronic kidney disease

Not yet recruiting
  • Chronic Kidney Diseases
  • Manifestation, Skin
  • observe pattern of mucocutaneous manifestations in chronic kidney disease patients
  • (no location specified)
Apr 6, 2023

Leishmaniasis, Cutaneous Trial in Gharyan (Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional

Recruiting
  • Leishmaniasis, Cutaneous
  • Intralesional Sodium stibogluconate
  • +3 more
  • Gharyan, Select Region, Libyan Arab Jamahiriya
    Dermatology department, Gharyan University Hospitals, Medical Co
Jan 31, 2023

Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Recruiting
  • Leishmaniasis
  • +2 more
    • Lankien, Jonglei, South Sudan
      Lankien Hospital
    Jul 4, 2022

    Performance of RPA-LF for Cutaneous Leishmaniasis

    Completed
    • Cutaneous Leishmaniasis (Diagnosis)
      • Cali, Valle, Colombia
        Corporación Centro Internacional de entrenamiento e Investigació
      Aug 3, 2020

      Erythema Multiforme Trial in Philadelphia (Apremilast)

      Recruiting
      • Erythema Multiforme
      • Philadelphia, Pennsylvania
        Perelman Center For Advanced Medicine
      May 16, 2023

      Primary Visceral Leishmaniasis Trial in Gondar (LXE408, sodium stibogluconate, Paromomycin)

      Not yet recruiting
      • Primary Visceral Leishmaniasis
      • Gondar, Ethiopia
        University of Gondar
      Jul 14, 2023

      Leishmaniasis, Cutaneous Leishmaniases, Insect Bites Trial in York (biting by Phlebotomus duboscqi infected with Leishmania

      Recruiting
      • Leishmaniasis
      • +2 more
      • biting by Phlebotomus duboscqi infected with Leishmania major
      • York, North Yorkshire, United Kingdom
        Translational Research Facility, Department of Biology, Universi
      Jan 20, 2022

      Cutaneous Leishmaniasis Diagnostic Study

      Active, not recruiting
      • Cutaneous Leishmaniases
      • Skin slit
      • +2 more
      • Gondar, Ethiopia
        Leishmania Research and Treatment Center, University of Gondar h
      Oct 27, 2022

      Cutaneous Leishmaniasis, American Trial in Presidente Tancredo Neves (Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony

      Completed
      • Cutaneous Leishmaniasis, American
      • Sm29 Protein, Schistosoma Mansoni
      • Pentavalent antimony (Sbv)
      • Presidente Tancredo Neves, Bahia, Brazil
        Corte de Pedra Health Post
      Aug 17, 2023

      Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

      Completed
      • Candidiasis, Chronic Mucocutaneous
      • Amphotericin B
      • Bethesda, Maryland
        National Institute of Allergy and Infectious Disease (NIAID)
      Aug 17, 2022